ST. LOUIS, July 26 /PRNewswire-FirstCall/ -- Stereotaxis, Inc. announced today that it intends to release its financial results for the quarter ended June 30, 2006 post-market on Wednesday, August 9, 2006. The Company will also host a conference call with the investment community the same day at 5:00 p.m. ET.
To participate in the conference call, please dial 877-427-0628 (Domestic) or 973-582-2844 (International) a few minutes before 5:00 p.m. ET on Wednesday, August 9, 2006. A replay of the conference call will be available from 7:00 p.m. ET on August 9, 2006 until 7:00 p.m. ET on November 9, 2006. The replay dial in number is 877-519-4471 (Domestic) or 973-341-3080 (International). The replay pin number is 7651062.
The call will also be available on the Internet live and for 90 days thereafter at the following URL:
http://www.videonewswire.com/event.asp?id=34875
About Stereotaxis
Stereotaxis designs, manufactures and markets an advanced cardiology instrument control system for use in a hospital’s interventional surgical suite to enhance the treatment of coronary artery disease and arrhythmias. The Stereotaxis System is designed to allow physicians to navigate catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. This is achieved using computer-controlled, externally applied magnetic fields that govern the motion of the working tip of the catheter or guidewire. Core components of the Stereotaxis System have received regulatory clearance in the U.S., Europe and Canada.
This press release includes statements that may constitute “forward- looking” statements, usually containing the words “believe,” “estimate,” “project,” “expect” or similar expressions. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, continued acceptance of the Company’s products in the marketplace, competitive factors, changes in government reimbursement procedures, dependence upon third-party vendors, and other risks discussed in the Company’s periodic filings with the Securities and Exchange Commission. By making these forward- looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release.
Contacts: Stereotaxis, Inc. Noonan Russo 314-678-6105 212-845-4269 Jim Stolze, Chief Financial Officer Brian Ritchie (investors) jstolze@stereotaxis.combrian.ritchie@eurorscg.com
Stereotaxis, Inc.
CONTACT: Jim Stolze, Chief Financial Officer of Stereotaxis, Inc.,+1-314-678-6105, jstolze@stereotaxis.com; or Brian Ritchie - investors,Noonan Russo, +1-212-845-4269, brian.ritchie@eurorscg.com
